Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Statistics in Medicine
|
March 19, 2020
Flexible regression approach to propensity score analysis and its relationship with matching and weighting
Huzhang Mao, Liang Li
Statistical Methods in Medical Research
|
June 21, 2018
Propensity score weighting analysis and treatment effect discovery
Huzhang Mao, Liang Li, Tom Greene
Statistics in Medicine
|
June 2, 2018
On the propensity score weighting analysis with survival outcome: Estimands, estimation, and inference
Huzhang Mao, Liang Li, Wei Yang, et al.
Biometrical Journal. Biometrische Zeitschrift
|
December 17, 2016
Estimating the prevalence of atrial fibrillation from a three-class mixture model for repeated diagnoses
Liang Li, Huzhang Mao, Hemant Ishwaran, et al.
Journal of the Endocrine Society
|
May 8, 2023
Tirzepatide as Monotherapy Improved Markers of Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes (SURPASS-1)
Clare J Lee, Huzhang Mao, Vivian T Thieu, et al.
Nucleic Acids Research
|
October 22, 2020
NMR structure of a vestigial nuclease provides insight into the evolution of functional transitions in viral dsDNA packaging motors
Bryon P Mahler, Paul J Bujalowski, Huzhang Mao, et al.
Cell Reports
|
February 25, 2016
Structural and Molecular Basis for Coordination in a Viral DNA Packaging Motor
Huzhang Mao, Mitul Saha, Emilio Reyes-Aldrete, et al.
Cancer Cell
|
May 12, 2016
Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients
Yuan Yuan, Lingxiang Liu, Hu Chen, et al.
Lancet (London, England)
|
June 29, 2021
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
Julio Rosenstock, Carol Wysham, Juan P Frías, et al.
BMC Urology
|
November 8, 2020
Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE)
Andrea Necchi, Hiroyuki Nishiyama, Nobuaki Matsubara, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Statistics in Medicine
|
March 19, 2020
Flexible regression approach to propensity score analysis and its relationship with matching and weighting
Huzhang Mao, Liang Li
Statistical Methods in Medical Research
|
June 21, 2018
Propensity score weighting analysis and treatment effect discovery
Huzhang Mao, Liang Li, Tom Greene
Statistics in Medicine
|
June 2, 2018
On the propensity score weighting analysis with survival outcome: Estimands, estimation, and inference
Huzhang Mao, Liang Li, Wei Yang, et al.
Biometrical Journal. Biometrische Zeitschrift
|
December 17, 2016
Estimating the prevalence of atrial fibrillation from a three-class mixture model for repeated diagnoses
Liang Li, Huzhang Mao, Hemant Ishwaran, et al.
Journal of the Endocrine Society
|
May 8, 2023
Tirzepatide as Monotherapy Improved Markers of Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes (SURPASS-1)
Clare J Lee, Huzhang Mao, Vivian T Thieu, et al.
Nucleic Acids Research
|
October 22, 2020
NMR structure of a vestigial nuclease provides insight into the evolution of functional transitions in viral dsDNA packaging motors
Bryon P Mahler, Paul J Bujalowski, Huzhang Mao, et al.
Cell Reports
|
February 25, 2016
Structural and Molecular Basis for Coordination in a Viral DNA Packaging Motor
Huzhang Mao, Mitul Saha, Emilio Reyes-Aldrete, et al.
Cancer Cell
|
May 12, 2016
Comprehensive Characterization of Molecular Differences in Cancer between Male and Female Patients
Yuan Yuan, Lingxiang Liu, Hu Chen, et al.
Lancet (London, England)
|
June 29, 2021
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
Julio Rosenstock, Carol Wysham, Juan P Frías, et al.
BMC Urology
|
November 8, 2020
Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RANGE)
Andrea Necchi, Hiroyuki Nishiyama, Nobuaki Matsubara, et al.
Page
of 2